Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 July 2020 | Story Valentino Ndaba
Add these emergency safety contacts to your speed dial.

Staying safe during the coronavirus pandemic extends to ensuring that students at the University of the Free State (UFS) are safe from crime. Crime in South Africa remains an unfortunate reality which continues to affect students, staff and the institution in general. 

“Crime requires constant vigilance from the community and this can only be achieved through initiatives that are aimed at informing the community on what to do and what not to do. To this end the BSafe Safety First flyer is geared at informing specifically the student community on safety measures that must be taken,” said Cobus van Jaarsveld, Assistant Director: Threat Detection, Investigations and Liaison at Protection Services.

The Safety First flyer is a guide for students to be crime-conscious whether at their accommodation, on the street, or in their vehicles. It also offers tips on how to act responsibly as far as alcohol and drugs are concerned.

Engaging students on their safety 

UFS Protection Services recently engaged with off-campus residence students in Bloemfontein in order to provide tips on how to stay safe in their neighbourhoods. During the engagement, the new Safety First pamphlets were distributed, and students were encouraged to join the Student Crime-Stop Brandwag WhatsApp group.

As from 15 June 2020, Nissi Armed Response was deployed from 18:00 to 06:00. This initiative has already led to them responding to several suspicious persons and vehicles, as well as some minor incidents and disturbances. Two arrests were made on different occasions as a result of the deployment. In the first incident, a suspect was arrested on 27 June 2020 after a burglary in Brandwag, and the second relates to a suspect who was arrested on 10 July 2020 after threatening students at Universitas.

These successes were the result of student and community participation in providing information, coupled with excellent response from private security companies, including Nissi Armed Response, VR Security, and BloemSec.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept